This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Anna Pasetto: Innovator in Cancer Immunotherapy
Introduction
Anna Pasetto is a prominent inventor based in Asker, Norway, known for her significant contributions to the field of cancer immunotherapy. With a focus on developing innovative treatments, she has made strides in the understanding and application of T cell receptors in combating cancer.
Latest Patents
Anna Pasetto holds a patent for "Anti-KRAS-G12D T cell receptors." This patent discloses an isolated or purified T cell receptor (TCR) that has antigenic specificity for the mutated Kirsten rat sarcoma viral oncogene homolog (KRAS), presented in the context of an HLA-Cw*0802 molecule. The patent also includes related polypeptides and proteins, as well as related nucleic acids, recombinant expression vectors, host cells, populations of cells, and pharmaceutical compositions. Furthermore, it outlines methods for detecting the presence of cancer in mammals and methods for treating or preventing cancer in mammals.
Career Highlights
Anna Pasetto has made significant contributions to her field while working for the Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services. Her work has been pivotal in advancing cancer treatment methodologies and enhancing the understanding of T cell receptor specificity.
Collaborations
Throughout her career, Anna has collaborated with notable professionals, including Eric Tran. These collaborations have fostered
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile